BCM
INSP icon

Bayesian Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bayesian Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,347
Closed -$504K – 912
2024
Q1 		$504K Buy
+2,347
New +$460K 0.05% 433
2022
Q2 		– Sell
-3,452
Closed -$886K – 923
2022
Q1 		$886K Buy
+3,452
New +$789K 0.13% 230
2021
Q3 		– Sell
-2,427
Closed -$469K – 456
2021
Q2 		$469K Sell
2,427
-887
-27% -$176K 0.12% 198
2021
Q1 		$686K Buy
+3,314
New +$704K 0.16% 166
2020
Q2 		– Sell
-11,997
Closed -$723K – 638
2020
Q1 		$723K Buy
+11,997
New +$888K 0.16% 197

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bayesian Capital Management's INSP Position: Q2 2024 in Review

Bayesian Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2024, closing a stake of 2,347 shares — an estimated $504K sold.

Bayesian Capital Management first reported a position in INSP in Q1 2020 and held it in 5 quarters. The position peaked at $886K in Q1 2022. 325 funds tracked by Wall St. Rank hold INSP as of Q2 2024.

  • Bayesian Capital Management reported no remaining Inspire Medical Systems position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 2,347 Inspire Medical Systems shares in Q2 2024, an estimated $504K.
  • Bayesian Capital Management first reported a position in Inspire Medical Systems in Q1 2020 and held it in 5 quarters.
  • Bayesian Capital Management's Inspire Medical Systems position peaked at $886K in Q1 2022.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.